Phase 2
N=241
Psychological Influences on Postoperative Recovery
Care, Postoperative · Pain, Postoperative · Surgical Procedures, Operative · Otorhinolaryngologic Surgical Procedures · Tonsillectomy
Bottom Line
View on ClinicalTrials.gov: NCT00581139 ↗Enrolled (actual)
241
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Modified Yale Preoperative Anxiety Scale — 41.59; 37.44; 46.17; 33.65 Score on mYPAS scale — p=.02
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Preoperative Preparation Program (Child Life Specialist) (Behavioral); Midazolam (Drug); Parental Presence during Induction of Anesthesia (Behavioral); PPIA preparation program PLUS Midazolam premedication (Other)
- Age
- Pediatric · 3+ yrs
- Sex
- All
- Sponsor
- University of California, Irvine
- Primary completion
- Apr 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Modified Yale Preoperative Anxiety Scale |
41.59; 37.44; 46.17; 33.65 | .02 sig |
| PRIMARY Percentage of Children Not Exhibiting Negative Behaviors, Fear, or Anxiety (Perfect Induction, 0) |
68; 83; 62; 86 | — |
| PRIMARY Percent of Children Crying During Induction |
32; 17; 38; 14 | .01 sig |
| PRIMARY Percentage of Children Arriving to PACU Awake |
55; 32; 32; 33 | .01 sig |
| PRIMARY Percentage of Children Arriving to PACU in Deep Sleep |
45; 68; 46; 67 | .01 sig |
| PRIMARY Post Anesthesia Care Unit (PACU) IV Fluid |
13.18; 16.85; 18.78; 22.21 | .02 sig |
| PRIMARY Visual Analogue Pain Scale (VAS) 24 Hour After Surgery |
34.13; 35.93; 38.30; 47.02 | .04 sig |
| PRIMARY Heart Rate in the General Clinical Research Unit (GCRC) |
96.75; 95.13; 97.39; 104.55 | .04 sig |
Summary
The primary hypothesis tested in this project is that the preoperative behavioral stress response predicts postoperative behavioral and clinical recovery of children undergoing surgery.
Eligibility Criteria
Inclusion Criteria
- Outpatient tonsillectomy or tonsils/adenoids
- ASA I, II
Exclusion Criteria
- Developmental delay
- ASA III-IV
- Psychotropic medication
- Meds which interfere with metabolism of midazolam
- 36 weeks gestation
Data sourced from ClinicalTrials.gov (NCT00581139). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.